D-0444-2022 Class II Terminated
FDA drug recall D-0444-2022 was initiated by Edge Pharma, LLC on Dec 6, 2021 and is designated Class II. Reason for recall: CGMP Deviations The recall status is terminated (terminated Jun 7, 2023). Affected quantity: 231 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 2, 2022
- Initiation Date
- Dec 6, 2021
- Termination Date
- Jun 7, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 231 bottles
Product description
Lidocaine HCl/Phenylephrine HCl Nasal Solution, 4%/1%, 240 mL per bottle, Multiple Dose Container, Edge Pharma, LLC 856 Hercules Dr., Colchester, VT 05446, NDC 05446-1045-03
Reason for recall
CGMP Deviations
Distribution pattern
nationwide
Code information
07-2021-02@7 12-29-2021, 07-2021-23@4 01-19-2022, 08-2021-11@7 02-07-2022, 08-2021-23@8 02-19-2022 & 09-2021-24@10 03-23-2022
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0444-2022
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026